Misetionamide

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameMisetionamide
Drug Alias Nameanalog of taurultamGP-2250
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsLipopolysaccharide (LPS) inhibitorsMyc proto-oncogene protein blockers +[4] 
TargetsMyc proto-oncogene proteinNuclear factor NF-kappa-B complex
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGeistlich Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPersevere Therapeutics IncGeistlich Pharma AG
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A